Levine Cancer Institute is a regional leader in diagnosing and treating lung cancer. Our multidisciplinary team is focused on using the latest technologies, treatments and research to provide our patients with the highest-quality care. Physicians meet regularly to discuss every patient's care and to develop a comprehensive treatment plan unique to individual needs, in consultation with the patient's referring physician.
The collaboration between physicians, support staff and patient navigators raises the quality of each patient's medical management. Our 12 Levine Cancer Institute locations throughout North Carolina and South Carolina means you get the care you need, where you need it.
Levine Cancer Institute is committed to offering breakthrough research that leads to innovative medical solutions. Our clinical trials for lung cancer are designed to improve the treatment of cancer as well as the treatment of recurrent or advanced cancer.
Learn more about our lung cancer clinical trials
The Scope of Lung Cancer
Lung cancer accounts for more cancer deaths than the next three common cancers – colon, breast and prostate – combined. More than 160,000 people will die from lung cancer this year, accounting for about 28 percent of all cancer deaths.